Leflunomide (LEF) versus low dose methotrexate (MTX) in adult Asian patients with active rheumatoid arthritis (RA)

published_or_final_versio

A new model of health identified through qualitative and quantitative analysis of the Chinese Arthritis Impact Measurement Scales 2. Cultural issues in the translation and validation of health status measures

published_or_final_versio

Effects of CD8+CD28- T suppressor lymphocyte (Ts) on B- and T-lymphocyte function in systemic lupus erythematosus (SLE)

published_or_final_versio

Drug therapy in rheumatoid arthritis

Rheumatoid arthritis is such a debilitating illness that much effort has been made to find the ideal therapeutic regimen that has a high efficacy but low toxicity rate. Although such regimen has not been found yet, judicious use of what are currently available can improve the outcome of many of our patients.published_or_final_versio

Management strategies for systemic lupus erythematosus

The management of systemic lupus erythematosus (SLE) is a challenging task. All interventions to-date are palliative rather than curative as the pathogenesis of the disease remains enigmatic. Treatment-related side effects can be as problematic as the disease itself. The following is a review of the practical management of the disease based on our experience.published_or_final_versio

Neuropsychiatric manifestations in southern Chinese patients with systemic lupus erythematosus (SLE) according to the 1999 ACR nomenclature and their clinical associations

published_or_final_versio

Antirheumatic drug prescribing pattern: a survey of Hong Kong physicians

published_or_final_versio

Intestinal pseudoobstruction is an uncommon but important clinical manifestation of systemic lupus erythematosus (SLE)

published_or_final_versio